Our previous study found that honokiol improved depression-like behaviors in LPS-induced depression mouse models by inhibiting the NF-κB signaling pathway and reducing the levels of pro-inflammatory cytokines (Zhang et al., 2019). Here, NFKB1 is linked to major depressive disorder.